MacFarlane Katie 4
4 · RespireRx Pharmaceuticals Inc. · Filed Aug 4, 2020
Insider Transaction Report
Form 4
MacFarlane Katie
Director
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-07-31+7,500,000→ 7,500,000 totalExercise: $0.01Exp: 2025-07-31→ Common Stock (7,500,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vested upon issuance.